Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
Omeros Corp (OMER)
NASDAQ:OMER
Omeros (OMER) Stock Price & Analysis
584 Followers
OMER Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.74 - $7.75
Previous Close$4.53
Volume361.76K
Average Volume (3M)932.32K
Market Cap
$284.61M
Enterprise Value$431.72M
Total Cash (Recent Filing)$194.92M
Total Debt (Recent Filing)$342.02M
Price to Earnings (P/E)6.0
Beta1.85
Next Earnings
May 11, 2023EPS Estimate
-$0.53Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.75
Shares Outstanding62,828,765
10 Day Avg. Volume309,821
30 Day Avg. Volume932,317
Standard Deviation0.22
R-Squared0.06
Alpha-0.00021
Financial Highlights & Ratios
Price to Book (P/B)2.83
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-2.80
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-2.73
Forecast
1Y Price Target
$4.00Price Target Upside-9.91% Downside
Rating ConsensusModerate Sell
Number of Analyst Covering2
Omeros News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
OMER FAQ
What was Omeros Corp’s price range in the past 12 months?
Omeros Corp lowest stock price was $1.74 and its highest was $7.75 in the past 12 months.
What is Omeros Corp’s market cap?
Currently, no data Available
When is Omeros Corp’s upcoming earnings report date?
Omeros Corp’s upcoming earnings report date is May 11, 2023 which is in 41 days.
How were Omeros Corp’s earnings last quarter?
Omeros Corp released its earnings results on Mar 13, 2023. The company reported $2.05 earnings per share for the quarter, beating the consensus estimate of -$0.566 by $2.616.
Is Omeros Corp overvalued?
According to Wall Street analysts Omeros Corp’s price is currently Overvalued.
Does Omeros Corp pay dividends?
Omeros Corp does not currently pay dividends.
What is Omeros Corp’s EPS estimate?
Omeros Corp’s EPS estimate is -$0.53.
How many shares outstanding does Omeros Corp have?
Omeros Corp has 62,828,766 shares outstanding.
What happened to Omeros Corp’s price movement after its last earnings report?
Omeros Corp reported an EPS of $2.05 in its last earnings report, beating expectations of -$0.566. Following the earnings report the stock price went up 9.275%.
Which hedge fund is a major shareholder of Omeros Corp?
Among the largest hedge funds holding Omeros Corp’s share is Sheaff Brock Investment Advisors LLC. It holds Omeros Corp’s shares valued at 143K.
---
Omeros Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Sell
Average Price Target:
$4.00 (-9.91% Downside)
$4.00 (-9.91% Downside)
Blogger Sentiment
Bullish
OMER Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 5.5K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 0.5%
Last 30 Days ▲ 3.7%
Last 30 Days ▲ 3.7%
News Sentiment
Positive
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-28.66%
12-Months-Change
Fundamentals
Return on Equity
-332.58%
Trailing 12-Months
Asset Growth
40.95%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Omeros Corp
Omeros Corp. operates as a biopharmaceutical company. It engages in the discovery, development, and commercializes of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.
---
Top 5 ETFs holding OMER
iShares Core S&P Total U.S. Stock Market ETF
$216.92K
Schwab U.S. Broad Market ETF
$150.63K
Up to five ETFs with an Outperform Smart Score that hold OMER. The ETFs are listed according to market value of OMER within the ETF
---
Assertio Therapeutics
―
RVL Pharmaceuticals
―
Relmada Therapeutics
―
Paratek Pharmaceuticals
―
---